Professor of Clinical Pediatrics
Prof. Philippe Backeljauw is a consultant for Novo Nordisk, Novartis/Sandoz, Tolmar Pharmaceuticals, Ascendis Pharma, BioMarin Pharmaceutical, Cavalry Biosciences and Ipsen, and currently receives research support from Novo Nordisk, Novartis and Ipsen
Video podcast exploring primary IGF-I deficiency, GH deficiency and other rare growth disorders
A micro learning programme from paediatric endocrinologists